American Journal of Kidney Diseases
Volume 51, Issue 5 , Pages 759-766 , May 2008

Predictive Power of Sequential Measures of Albuminuria for Progression to ESRD or Death in Pima Indians With Type 2 Diabetes

Received 7 June 2007 ,Accepted 22 January 2008.

References 

  1. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003;348:2285–2293
  2. Araki S, Haneda M, Sugimoto T, et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes. 2005;54:2983–2987
  3. Spoelstra-de Man AME, Brouwer CB, Stehouwer CDA, Smulders YM. Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microalbuminuria. Diabetes Care. 2001;24:2097–2101
  4. Gaede P, Tarnow L, Vedel P, Parving HH, Pedersen O. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrol Dial Transplant. 2004;19:2784–2788
  5. Rossing K, Christensen PK, Hovind P, Parving HH. Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients. Diabetologia. 2005;48:2241–2247
  6. Hovind P, Tarnow L, Parving HH. Remission and regression of diabetic nephropathy. Curr Hypertens Rep. 2004;6:377–382
  7. Vasquez B, Flock EV, Savage PJ, et al. Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycemia. Diabetologia. 1984;26:127–133
  8. Chasson AL, Grady HJ, Stanley MA. Determination of creatinine by means of automatic chemical analysis. Tech Bull Regist Med Technol. 1960;30:207–212
  9. World Health Organization. Diabetes Mellitus (Technical Report Series No. 727). Geneva, Switzerland: World Health Organization; 1985;
  10. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation. Stat Med. 2004;23:2109–2123
  11. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839–843
  12. Song HH. Analysis of correlated ROC areas in diagnostic testing. Biometrics. 1997;53:370–382
  13. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest. 1997;99:342–348
  14. Jafar TH, Stark PC, Schmid CH, et al. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int. 2001;60:1131–1140
  15. Remuzzi A, Gagliardini E, Sangalli F, et al. ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney Int. 2006;69:1124–1130
  16. Remuzzi A, Gagliardini E, Donadoni C. Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Kidney Int. 2002;62:885–894
  17. Nosadini R, Velussi M, Brocco E, et al. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes. 2000;49:476–484
  18. Fioretto P, Steffes MW, Sutherland DER, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998;339:69–75
  19. Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet. 2001;357:1601–1608
  20. Vasan RS, Massaro JM, Wilson PWF, et al. Antecedent blood pressure and risk of cardiovascular disease (The Framingham Heart Study). Circulation. 2002;105:48–53
  21. Boshuizen HC, Lanti M, Menotti A, et al. Effects of past and recent blood pressure and cholesterol level on coronary heart disease and stroke mortality, accounting for measurement error. Am J Epidemiol. 2006;165:398–409
  22. Caramori ML, Fioretto P, Mauer M. Enhancing the predictive value of urinary albumin for diabetic nephropathy. J Am Soc Nephrol. 2006;17:339–352
  23. Christensen PK, Larsen S, Horn T, Olsen S, Parving HH. Renal function and structure in albuminuric type 2 diabetes without retinopathy. Nephrol Dial Transplant. 2001;16:2337–2347
  24. Fioretto P, Mauer SM, Brocco E, et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia. 1996;39:1569–1576
  25. Nelson RG, Bennett PH, Beck GJ, et al. for the Diabetic Renal Disease Study Group: Development and progression of renal disease in Pima Indians with non-insulin dependent diabetes mellitus. N Engl J Med. 1996;335:1636–1642
  26. Lemley KV, Blouch K, Abdullah I, et al. Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol. 2000;11:2095–2105
  27. Tu Y-K, West R, Ellison GTH, Gilthorpe MS. Why evidence for the fetal origins of adult disease might be a statistical artifact: The “reversal paradox” for the relation between birth weight and blood pressure in later life. Am J Epidemiol. 2005;161:27–32
  28. Cole TJ. Re: Why evidence for the fetal origins of adult disease might be a statistical artifact: The “reversal paradox” for the relation between birth weight and blood pressure in later life. Am J Epidemiol. 2005;162:394–395(letter)

 Originally published online as doi:10.1053/j.ajkd.2008.01.011 on March 13, 2008.

PII: S0272-6386(08)00061-9

doi: 10.1053/j.ajkd.2008.01.011

American Journal of Kidney Diseases
Volume 51, Issue 5 , Pages 759-766 , May 2008

Article Tools

* Image Usage & Resolution